Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Martin Landray

Covid, five years on: UK ‘still not ready to protect the population’

Scientific triumphs were made in the battle against the pandemic, but the memories and lessons are already in danger of being lost

The Guardian - UK · Mar 9, 2025

NHS cannot embrace AI until its basic IT systems are up to scratch

Prof Sir Martin Landray: clinical IT functions are slow and ‘devastatingly user unfriendly’

The Guardian - UK · Sep 15, 2024

The Observer view on the NHS: If it is to ‘reform or die’, let’s start with the way it handles our data

Properly organised, the mammoth database of medical information the health service holds has vast potential in the exploration of new treatments

The Guardian - UK · Sep 15, 2024

From analysis to the latest developments in health,
read the most diverse news in one place.

Dismay as UK government halts cash for world-renowned Covid programme

Despite its trials saving thousands during the pandemic, funding is being stopped for the groundbreaking UK Recovery programme

The Guardian - UK · Mar 3, 2024

The inside story of the ground-breaking Covid-19 Recovery trial

When the effectiveness of dexamethasone was first announced, it changed the treatment of the disease overnight, Guilherme Pessoa-Amorim, Leon Peto and Mark Campbell explain how they did it

The Independent UK · Jul 9, 2022

The inside story of Recovery: how the world’s largest COVID-19 trial transformed treatment – and what it could do for other diseases

Guilherme – June 16, 2020. Evening TV news shows across the world were suddenly opening with the result of our research, and rightly so. Dexamethasone was the first drug to be shown to save the lives of people infected with COVID-19. To a young researcher like me, that day felt…

The Conversation · Jun 15, 2022

Will AI turbocharge the hunt for new drugs?

Advocates point to the pandemic as proof of its value in healthcare even as critics dismiss its use in drug discovery as ‘hype’

Financial Times · Mar 20, 2022

Read news from The Economist, FT, and more,
with one subscription

Arthritis drug could help save Covid patients – study

Rheumatoid arthritis drug baricitinib can reduce risk of death from severe Covid by about a fifth

The Guardian - UK · Mar 3, 2022

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Oxford Population Health

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.